PR Needed NEW Request / Thyroid Molecular Tests - THYROSEQ 5 year contract
Veterans Affairs · 260-NETWORK CONTRACT OFFICE 20 (36C260)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26026Q0888 in this department, oldest first.
- Aug 4, 2026 · this noticeSolicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Molecular testing of thyroid nodule FNA specimens has been found to assist in the assessment of indeterminate thyroid nodules. Molecular testing can detect genetic alterations associated with thyroid malignancy.
Who won similar work
24 award notices on SAM.gov in the last 24 months. Matched by: Same office (260-NETWORK CONTRACT OFFICE 20 (36C260)), same product/service code (PSC) 6515.
Single-winner award sizes (23): middle half $52K to $2.0M, median $363K; range $14K to $4.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| CAREFUSION SOLUTIONS, LLC · $BDX · $22.5B | 3 | $5.2M | Sep 22, 2025 |
| GULDMANN, INC. | 2 | $5.2M | Aug 6, 2026 |
| ELECTRONIC WAVEFORM LAB, INC. | 1 | $3.7M | Jun 26, 2025 |
| CEPHEID INC | 1 | $3.0M | Oct 1, 2026 |
| CYTOPATH BIOPSY LAB INC | 1 | $2.5M | Oct 1, 2026 |
| PREMIER MEDICAL DISTRIBUTORS, LLC | 1 | $2.0M | Jun 18, 2026 |
| BRANCH MEDICAL LLC · $GMED · $3.1B | 1 | $1.5M | Jan 22, 2026 |
| FIDELIS SUSTAINABILITY DISTRIBUTION, LLC | 1 | $381K | Mar 20, 2025 |
| KARL STORZ ENDOSCOPY-AMERICA INC | 1 | $363K | Sep 11, 2025 |
| ADVANCED STERILIZATION PRODUCTS SERVICES INC. | 1 | $332K | Jun 10, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either (1 here). Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $BDX reported $22.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 23 past awards, $363K, is under 0.1% of that. SEC filing
- $GMED reported $3.1B revenue (12 months to Jun 30, 2026). The median single-winner award in these 23 past awards, $363K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026CEPHEID INC$3.0MPurchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMCNo listed company matched (Materiality N/A)
- Oct 1, 2026CYTOPATH BIOPSY LAB INC$2.5MPR Needed NEW Request / Thyroid Molecular Tests - THYROSEQ 5 year contractNo listed company matched (Materiality N/A)
- Sep 8, 20261ST AMERICAN MEDICAL DISTRIBUTORS, INC.$41K6515--Thyroid Uptake SystemNo listed company matched (Materiality N/A)
- Aug 6, 2026GULDMANN, INC.$4.6MSeattle Lift ReplacementNo listed company matched (Materiality N/A)
- Jun 18, 2026PREMIER MEDICAL DISTRIBUTORS, LLC$2.0M6515--Patient Ceiling Lift SystemsNo listed company matched (Materiality N/A)
- Apr 29, 2026HAMILTON COMPANY$185K6515 Automated Liquid Handling SystemNo listed company matched (Materiality N/A)
- Mar 24, 2026GULDMANN, INC.$549K6515--Patient Ceiling Lifts and InstallationNo listed company matched (Materiality N/A)
- Feb 11, 2026SCDATACOM Seattle WA 98108 USA$55KReplacement of 19 MICU/SICU cameras at Seattle VA Med CtrNo listed company matched (Materiality N/A)
- Feb 2, 2026LOTUSUSA, INC.$18K6515--New Respiratory Air FilteringNo listed company matched (Materiality N/A)
- Jan 22, 2026BRANCH MEDICAL LLC$1.5MDistribution of Biorad Bioplex Reagents and Consumables for Laboratory Tests.Materiality: 0.05% of $GMED revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $25K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 4 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.